This page is currently not available in English.
The content is therefore displayed in German.
A microchip-based process analytical technologies (PAT) platform tailored for autologous cell therapies (ACTs) manufacturing fulfilling the one patient - one batch paradigm will be developed.
A microchip-based process analytical technologies (PAT) platform tailored for autologous cell therapies (ACTs) manufacturing fulfilling the one patient - one batch paradigm will be developed.